The 14th Annual International Symposium on Left Atrial Appendage (ISLAA) will be held March 6–7, 2026, as a hybrid in-person and virtual educational program jointly provided by the Academy for Continued Healthcare Learning (ACHL) and the ISLAA Foundation. Designed for physicians, advanced practice providers, nurses, and allied health professionals in electrophysiology, cardiology, and internal and family medicine, the symposium focuses on the latest science and clinical advancements related to the left atrial appendage (LAA), including anatomy, physiology, pathophysiology, standards of care, and emerging stroke prophylaxis therapies such as cardiac devices for LAA exclusion. The program will feature didactic lectures, panel discussions, debates, and live case-based discussions led by globally recognized experts, with content developed in collaboration with course directors from the Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Los Robles Medical Center, Mayo Clinic, and Mount Sinai.

Learning Objectives

• Compare and contrast DOACs for efficacy and safety, while emphasizing the patient populations for whom they
are best suited.
• Review evidence-based guidelines and best clinical approaches to thromboprophylaxis.
• Assess the cost-effectiveness of systemic anticoagulation versus LAA exclusion technologies for stroke prophylaxis.
• Review the role of oral anticoagulation in stroke prophylaxis.
• Describe systemic thromboembolization and the role of LAA in patients with atrial fibrillation.
• Express a working knowledge of the role(s) of LAA in specific patient subgroups (ie, OAC treatment-(in)eligible, prescription failure).
• Discuss treatment options for the management of postoperative pericardial inflammation.
• Identify needle devices which can be utilized in specific patients to minimize complications associated with epicardial access.
• Review device types and techniques which may be employed to mitigate an incomplete LAA closure.

Our Sponsors

Academy for Continued Healthcare Learning – is the accrediting provider.

Sponsors include: Medtronic, Abbott, AtriCure, Lifetech, Biosense Webster and potentially others.

Location

The Biltmore Hotel

506 South Grand Avenue
Los Angeles, CA
United States

Program Directors

Dr. Dhanunjaya Lakkireddy

Dr. Andrea Natale

Dr. David Holmes

Dr. Saibal Kar

Dr. Vivek Reddy

Location
  • The Biltmore Hotel
    • Los Angeles
    • CA
    • United States
  • See map here
Topic

  • Atrial Fibrillation
  • Clinical EP

Delivery Method

In-Person, Virtual

Certifications

ABIM/AOBIM, ACE/MO, CME

Event Type

Synchrony